Physician profile
Ron Sklash
NPI 1598914574
$17,741.92
in general payments reported to CMS, 2019-2025
53 companies · $1,805 in 2025
The $1,805 reported for 2025 was more than what 82% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,944 · 2020: $1,911 · 2021: $2,454 · 2022: $3,321 · 2023: $2,655 · 2024: $2,652 · 2025: $1,805.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,112.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,112.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $2,676.48 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $2,000.54 | 2019-2024 | Xarelto |
| Pfizer INC. | $1,408.10 | 2019-2025 | |
| Astrazeneca Pharmaceuticals Lp | $1,342.31 | 2019-2025 | Farxiga, Brilinta, Wainua |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,337.96 | 2019-2025 | Jardiance |
| Amgen INC. | $1,304.26 | 2019-2025 | Repatha, Repatha |
| Sanofi-Aventis U.S. LLC | $797.72 | 2019-2024 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $701.00 | 2019-2025 | Lifevest |
| E.R. Squibb & Sons, L.L.C. | $662.60 | 2019-2025 | Camzyos, Eliquis |
| Merck Sharp & Dohme LLC | $642.48 | 2021-2024 | Verquvo |
| Abbott Laboratories | $453.59 | 2021-2024 | Cardiomems, Perclose Prostyle |
| Esperion Therapeutics, INC. | $340.25 | 2020-2025 | Nexletol |
| Medtronic, INC. | $336.51 | 2021-2025 | Pulseselect, Micra |
| Alnylam Pharmaceuticals INC. | $333.97 | 2022-2025 | Amvuttra |
| Amarin Pharma, INC. | $236.86 | 2019-2021 |
Show all 53 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kiniksa Pharmaceuticals, Ltd. | $234.05 | 2021-2023 | Arcalyst |
| Boston Scientific Corporation | $206.02 | 2019-2025 | Watchman Flx, Watchman Access System, Bodyguardian |
| Kestra Medical Technology Services, INC. | $188.41 | 2022-2025 | Assure Wcd |
| Bayer Healthcare Pharmaceuticals INC. | $182.59 | 2019-2025 | |
| Astellas Pharma US INC | $179.94 | 2019 | |
| W. L. Gore & Associates, INC. | $175.49 | 2020-2021 | |
| Arbor Pharmaceuticals, INC. | $161.24 | 2019-2022 | |
| Regeneron Healthcare Solutions, INC. | $160.70 | 2019-2021 | |
| Cardiva Medical, INC. | $136.58 | 2020-2024 | Cardiva Vascade Mvp Vvcs 6-12f |
| Kiniksa Pharmaceuticals International, Plc | $129.15 | 2024 | Arcalyst |
| Actelion Pharmaceuticals US, INC. | $119.00 | 2019-2021 | |
| Heartflow, INC. | $118.60 | 2019-2023 | Ffrct |
| Cvrx, INC. | $104.56 | 2022-2024 | Barostim Neo System |
| Medtronic Vascular, INC. | $82.53 | 2019 | |
| Bridgebio Pharma, INC. | $81.83 | 2025 | Attruby |
| Scpharmaceuticals INC. | $77.02 | 2024-2025 | |
| Biotronik INC. | $73.15 | 2019-2025 | Selectra |
| Lexicon Pharmaceuticals, INC. | $66.82 | 2023 | Inpefa |
| Impulse Dynamics (USA) INC. | $66.00 | 2022 | |
| Gilead Sciences, INC. | $61.74 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $59.80 | 2019 | |
| Altathera Pharmaceuticals LLC | $57.12 | 2025 | Sotalol Hydrochloride |
| Abiomed | $54.13 | 2022 | |
| Corindus INC. | $36.11 | 2019 | |
| Novo Nordisk INC | $35.68 | 2021 | |
| Baxter Healthcare | $30.21 | 2023 | Hillrom - Cardiac Ambulatory Monitor |
| Amicus Therapeutics, INC. | $28.74 | 2023 | |
| Inspire Medical Systems, INC. | $28.43 | 2025 | Inspire |
| Daiichi Sankyo INC. | $28.29 | 2023 | Injectafer |
| Ani Pharmaceuticals, INC. | $28.22 | 2024 | Purified Cortrophin Gel |
| Bardy Diagnostics, INC. | $25.68 | 2020-2022 | |
| Genzyme Corporation | $23.37 | 2019 | |
| Irhythm Technologies, INC. | $23.32 | 2019 | |
| Davol INC. | $23.25 | 2024 | Arista Ah Flexitip |
| Biom'Up France Sas | $22.06 | 2020 | |
| Cardiofocus, INC. | $20.50 | 2023 | Heartlight System |
| Smith+Nephew, INC. | $19.45 | 2022 | |
| Philips North America LLC | $17.51 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ron Sklash listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.